234 related articles for article (PubMed ID: 34099355)
61. Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.
Kawaguchi Y; Lillemoe HA; Panettieri E; Chun YS; Tzeng CD; Aloia TA; Kopetz S; Vauthey JN
J Am Coll Surg; 2019 Sep; 229(3):286-294.e1. PubMed ID: 31054911
[TBL] [Abstract][Full Text] [Related]
62. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
Okuno M; Goumard C; Kopetz S; Vega EA; Joechle K; Mizuno T; Omichi K; Tzeng CD; Chun YS; Vauthey JN; Conrad C
Ann Surg Oncol; 2018 Aug; 25(8):2457-2466. PubMed ID: 29786130
[TBL] [Abstract][Full Text] [Related]
63. Reevaluating the prognostic value of RAS mutation status in patients with resected liver metastases from colorectal cancer: A systematic review and meta-analysis.
Pikoulis E; Papaconstantinou D; Pikouli A; Wang J; Theodoridis C; Margonis GA
J Hepatobiliary Pancreat Sci; 2021 Aug; 28(8):637-647. PubMed ID: 34115442
[TBL] [Abstract][Full Text] [Related]
64. The predictors and oncological outcomes of repeat surgery for recurrence after hepatectomy for colorectal liver metastases.
Imai K; Yamashita YI; Miyamoto Y; Nakagawa S; Okabe H; Hashimoto D; Chikamoto A; Baba H
Int J Clin Oncol; 2018 Oct; 23(5):908-916. PubMed ID: 29619592
[TBL] [Abstract][Full Text] [Related]
65. Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment.
Buisman FE; Giardiello D; Kemeny NE; Steyerberg EW; Höppener DJ; Galjart B; Nierop PMH; Balachandran VP; Cercek A; Drebin JA; Gönen M; Jarnagin WR; Kingham TP; Vermeulen PB; Wei AC; Grünhagen DJ; Verhoef C; D'Angelica MI; Koerkamp BG
Eur J Cancer; 2022 Jun; 168():25-33. PubMed ID: 35430383
[TBL] [Abstract][Full Text] [Related]
66. Impact of Surgical Treatment for Recurrence After 2-Stage Hepatectomy for Colorectal Liver Metastases, on Patient Outcome.
Imai K; Benitez CC; Allard MA; Vibert E; Cunha AS; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
Ann Surg; 2019 Feb; 269(2):322-330. PubMed ID: 28820745
[TBL] [Abstract][Full Text] [Related]
67. Characterization of early recurrences following liver resection by ALPPS and two stage hepatectomy in patients with colorectal liver-metastases and small future liver remnants; a translational substudy of the LIGRO-RCT.
Røsok BI; Høst-Brunsell T; Brudvik KW; Carling U; Dorenberg E; Björnsson B; Lothe RA; Bjørnbeth BA; Sandström P
HPB (Oxford); 2019 Aug; 21(8):1017-1023. PubMed ID: 30765198
[TBL] [Abstract][Full Text] [Related]
68. Repeat hepatectomy justified in patients with early recurrence of colorectal cancer liver metastases: A systematic review and meta-analysis.
Hellingman T; de Swart ME; Heymans MW; Jansma EP; van der Vliet HJ; Kazemier G
Cancer Epidemiol; 2021 Oct; 74():101977. PubMed ID: 34303642
[TBL] [Abstract][Full Text] [Related]
69. Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients.
Margonis GA; Buettner S; Andreatos N; Wagner D; Sasaki K; Barbon C; Beer A; Kamphues C; Løes IM; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Mischinger HJ; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
Ann Surg; 2019 Jun; 269(6):1129-1137. PubMed ID: 31082912
[TBL] [Abstract][Full Text] [Related]
70. Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases.
Sakai N; Furukawa K; Takayashiki T; Kuboki S; Takano S; Ohtsuka M
BMC Cancer; 2021 Apr; 21(1):412. PubMed ID: 33858364
[TBL] [Abstract][Full Text] [Related]
71. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
[TBL] [Abstract][Full Text] [Related]
72. Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection.
Garajova I; Balsano R; Tommasi C; Dalla Valle R; Pedrazzi G; Ravaioli M; Spallanzani A; Leonardi F; Santini C; Caputo F; Riefolo M; Giuffrida M; Gelsomino F
Acta Biomed; 2020 Dec; 92(1):e2021061. PubMed ID: 33682832
[TBL] [Abstract][Full Text] [Related]
73. Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.
Uutela A; Nordin A; Osterlund E; Halonen P; Kallio R; Soveri LM; Salminen T; Ålgars A; Ristimäki A; Ovissi A; Lamminmäki A; Muhonen T; Kononen J; Ristamäki R; Heervä E; Stedt H; Lehtomäki K; Kytölä S; Sundström J; Mäkinen MJ; Nieminen L; Kuopio T; Keinänen M; Osterlund P; Isoniemi H;
Br J Surg; 2023 Jul; 110(8):931-935. PubMed ID: 36511370
[No Abstract] [Full Text] [Related]
74. The Impact of Perioperative Red Blood Cell Transfusions on Long-Term Outcomes after Hepatectomy for Colorectal Liver Metastases.
Hallet J; Tsang M; Cheng ES; Habashi R; Kulyk I; Hanna SS; Coburn NG; Lin Y; Law CH; Karanicolas PJ
Ann Surg Oncol; 2015 Nov; 22(12):4038-45. PubMed ID: 25752895
[TBL] [Abstract][Full Text] [Related]
75. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
[TBL] [Abstract][Full Text] [Related]
76. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
Tie J; Wang Y; Cohen J; Li L; Hong W; Christie M; Wong HL; Kosmider S; Wong R; Thomson B; Choi J; Fox A; Field K; Burge M; Shannon J; Kotasek D; Tebbutt NC; Karapetis C; Underhill C; Haydon A; Schaeffer J; Ptak J; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
PLoS Med; 2021 May; 18(5):e1003620. PubMed ID: 33939694
[TBL] [Abstract][Full Text] [Related]
77. The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.
Wang K; Xu D; Yan XL; Poston G; Xing BC
Eur J Surg Oncol; 2018 Jun; 44(6):771-777. PubMed ID: 29580735
[TBL] [Abstract][Full Text] [Related]
78. Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
Løes IM; Immervoll H; Sorbye H; Angelsen JH; Horn A; Knappskog S; Lønning PE
Int J Cancer; 2016 Aug; 139(3):647-56. PubMed ID: 26991344
[TBL] [Abstract][Full Text] [Related]
79. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
[TBL] [Abstract][Full Text] [Related]
80. Prognostic indicators lose their value with repeated resection of colorectal liver metastases.
Schmidt T; Nienhüser H; Kuna C; Klose J; Strowitzki MJ; Büchler MW; Ulrich A; Schneider M
Eur J Surg Oncol; 2018 Oct; 44(10):1610-1618. PubMed ID: 30115500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
